IR tacrolimus

DRUG2 trials

Sponsors

University of California, Davis, Academisch Medisch Centrum

Conditions

Drug ToxicityKidney Transplant; ComplicationsNeurotoxicityToxicitylung transplant recipients lung transplantation

Phase 3

*Randomized controlled prospEctiVe trial comparing extended-release with immediate-release tacrOlimus; reducing calcineurin inhibitor related toxicity in LUng TransplantatION patients*

RecruitingNL-OMON53377

Academisch Medisch Centrumlung transplant recipients lung transplantation

Start: 2020-07-28Target: 145Updated: 2024-02-28

Phase 4

Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients

CompletedNCT03461445

University of California, DavisDrug Toxicity, Kidney Transplant; Complications, Neurotoxicity +1

Start: 2018-04-01End: 2023-07-31Updated: 2025-04-08